Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $1.173B (100.0% shares, 0.0% debt)

Holdings (29)

BMRN BIOMARIN PHARMACEUTICAL INC 16.6%
Value $195M Shares 1,885,811 Share Price $103.49 * Est. Cost/Share $83.16 Unrealized @ Report Date +12.9%
UTHR UNITED THERAPEUTICS CORP 14.8%
Value $174M Shares 625,414 Share Price $278.09 * Est. Cost/Share $89.23 Unrealized @ Report Date +182.9%
FOLD AMICUS THERAPEUTICS INC 10.9%
Value $128M Shares 10,493,722 Share Price $12.21 * Est. Cost/Share $9.63 Unrealized @ Report Date +17.0%
INSM INSMED INC 10.0%
Value $117M Shares 5,871,291 Share Price $19.98 * Est. Cost/Share $17.79 Unrealized @ Report Date +8.6%
BIIB BIOGEN INC 9.0%
Value $105M Shares 380,082 Share Price $276.92 Est. Cost/Share $264.98 Unrealized @ Report Date +6.6%
PRTA PROTHENA CORP PLC 8.5%
Value $99.93M Shares 1,658,577 Share Price $60.25 * Est. Cost/Share $21.46 Unrealized @ Report Date +172.9%
— REVANCE THERAPEUTICS INC 8.3%
Value $97.54M Shares 5,283,609 Share Price $18.46 Est. Cost/Share $21.40 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 5.1%
Value $60.19M Shares 1,240,077 Share Price $48.54 * Est. Cost/Share $19.87 Unrealized @ Report Date +215.7%
ACAD ACADIA PHARMACEUTICALS INC 3.2%
Value $37.83M Shares 2,376,369 Share Price $15.92 Est. Cost/Share $28.53 Unrealized @ Report Date -45.2%
— SAGE THERAPEUTICS INC 2.8%
Value $32.67M Shares 856,517 Share Price $38.14 Est. Cost/Share $46.62 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 1.6%
Value $19.23M Shares 5,655,676 Share Price $3.40 Est. Cost/Share $16.36 Unrealized @ Report Date —
ALKS ALKERMES PLC 1.3%
Value $15.77M Shares 603,400 Share Price $26.13 * Est. Cost/Share $22.36 Unrealized @ Report Date +7.0%
ALGN ALIGN TECHNOLOGY INC 1.3%
Value $15.73M Shares 74,605 Share Price $210.90 * Est. Cost/Share $149.18 Unrealized @ Report Date +34.2%
SNDX SYNDAX PHARMACEUTICALS INC 1.3%
Value $15.59M Shares 612,600 Share Price $25.45 * Est. Cost/Share $16.84 Unrealized @ Report Date +38.5%
ANAB ANAPTYSBIO INC 1.1%
Value $13.36M Shares 431,024 Share Price $30.99 * Est. Cost/Share $19.06 Unrealized @ Report Date +48.2%
EHTH EHEALTH INC 1.0%
Value $12.02M Shares 2,484,479 Share Price $4.84 * Est. Cost/Share $41.23 Unrealized @ Report Date -91.0%
VNDA VANDA PHARMACEUTICALS INC 0.7%
Value $8.037M Shares 1,087,607 Share Price $7.39 * Est. Cost/Share $11.21 Unrealized @ Report Date -13.2%
CYTK CYTOKINETICS INC 0.4%
Value $5.119M Shares 111,717 Share Price $45.82 * Est. Cost/Share $6.71 Unrealized @ Report Date +539.8%
— KEZAR LIFE SCIENCES INC 0.4%
Value $4.62M Shares 656,200 Share Price $7.04 Est. Cost/Share $5.16 Unrealized @ Report Date —
— PROVENTION BIO INC 0.4%
Value $4.131M Shares 390,800 Share Price $10.57 Est. Cost/Share $4.50 Unrealized @ Report Date —
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value $3.492M Shares 166,069 Share Price $21.03 Est. Cost/Share $23.56 Unrealized @ Report Date -10.0%
— GRITSTONE ONCOLOGY INC 0.2%
Value $2.298M Shares 666,127 Share Price $3.45 Est. Cost/Share $9.42 Unrealized @ Report Date —
— PEAK BIO INC 0.2%
Value $2.022M Shares 497,528 Share Price $4.06 Est. Cost/Share $4.06 Unrealized @ Report Date —
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value $1.262M Shares 64,700 Share Price $19.50 Est. Cost/Share $15.56 Unrealized @ Report Date +27.1%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $1.119M Shares 160,800 Share Price $6.96 * Est. Cost/Share $7.10 Unrealized @ Report Date -19.4%
— ALIMERA SCIENCES INC 0.0%
Value $544K Shares 200,919 Share Price $2.71 Est. Cost/Share $6.30 Unrealized @ Report Date —
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value $311K Shares 27,100 Share Price $11.48 * Est. Cost/Share $39.74 Unrealized @ Report Date -77.9%
URGN UROGEN PHARMA LTD 0.0%
Value $217K Shares 24,500 Share Price $8.87 * Est. Cost/Share $27.01 Unrealized @ Report Date -64.9%
GOSS GOSSAMER BIO INC 0.0%
Value $81,918 Shares 37,750 Share Price $2.17 * Est. Cost/Share $11.85 Unrealized @ Report Date -30.5%